Zavicefta यूरोपीय संघ - स्लोवेनियाई - EMA (European Medicines Agency)

zavicefta

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibacterials za sistemsko uporabo, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.

Zavicefta 2 g/0,5 g prašek za koncentrat za raztopino za infundiranje स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

zavicefta 2 g/0,5 g prašek za koncentrat za raztopino za infundiranje

pfizer ireland pharmaceuticals - ceftazidim, avibaktam - prašek za koncentrat za raztopino za infundiranje - ceftazidim 2 g / 1 viala; avibaktam 0,5 g / 1 viala - ceftazidim in zaviralec laktamaz beta

Sivextro यूरोपीय संघ - स्लोवेनियाई - EMA (European Medicines Agency)

sivextro

merck sharp & dohme b.v. - tedizolidolidov fosfat - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.